ATE528308T1 - Gekoppelte azaindol-indol-derivate, herstellungsverfahren und anwendungen davon - Google Patents

Gekoppelte azaindol-indol-derivate, herstellungsverfahren und anwendungen davon

Info

Publication number
ATE528308T1
ATE528308T1 AT08757639T AT08757639T ATE528308T1 AT E528308 T1 ATE528308 T1 AT E528308T1 AT 08757639 T AT08757639 T AT 08757639T AT 08757639 T AT08757639 T AT 08757639T AT E528308 T1 ATE528308 T1 AT E528308T1
Authority
AT
Austria
Prior art keywords
azaindole
coupled
derivatives
indole
applications
Prior art date
Application number
AT08757639T
Other languages
English (en)
Inventor
Qizheng Yao
Zhaohui Wang
Weiyi Hua
Original Assignee
Cheng Jingcai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cheng Jingcai filed Critical Cheng Jingcai
Application granted granted Critical
Publication of ATE528308T1 publication Critical patent/ATE528308T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT08757639T 2007-06-08 2008-06-06 Gekoppelte azaindol-indol-derivate, herstellungsverfahren und anwendungen davon ATE528308T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2007100233478A CN101074229B (zh) 2007-06-08 2007-06-08 7-氮杂靛玉红和7-氮杂异靛蓝衍生物制备及其药学用途
PCT/CN2008/071228 WO2008151558A1 (en) 2007-06-08 2008-06-06 Azaindole-indole coupled derivatives, preparation methods and uses thereof

Publications (1)

Publication Number Publication Date
ATE528308T1 true ATE528308T1 (de) 2011-10-15

Family

ID=38975520

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08757639T ATE528308T1 (de) 2007-06-08 2008-06-06 Gekoppelte azaindol-indol-derivate, herstellungsverfahren und anwendungen davon

Country Status (10)

Country Link
US (1) US8642765B2 (de)
EP (1) EP2168964B1 (de)
JP (1) JP5216083B2 (de)
KR (1) KR101191851B1 (de)
CN (2) CN101074229B (de)
AT (1) ATE528308T1 (de)
AU (1) AU2008261491B2 (de)
CA (1) CA2692922C (de)
IL (1) IL202600A (de)
WO (1) WO2008151558A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030069692A (ko) * 2002-02-22 2003-08-27 신학기 아파타이트 결정을 갖는 경량골재의 제조방법
EP2379549B1 (de) 2008-12-22 2016-09-21 Eisenbrand, Gerhard 7-azaindirubine, 7'-azainrubine, 7-7'-diazainrubin und entsprechende 3'-oximetherderivate: herstellung davon, herstellung und verwendung als medikament
EP2199292A1 (de) 2008-12-22 2010-06-23 Technische Universität Kaiserlautern 7-azaindirubine, 7'-azainrubine, 7-7'-diazainrubin und entsprechende 3'-oximetherderivate: Herstellung davon, Herstellung und Verwendung als Medikament
CN101492448B (zh) * 2009-03-05 2012-09-19 上海交通大学 用于抗肿瘤药物的7＇-氮杂靛玉红类化合物
US20140005070A1 (en) * 2011-03-28 2014-01-02 Novartis Ag Markers associated with cyclin-dependent kinase inhibitors
WO2013142817A2 (en) 2012-03-23 2013-09-26 Dennis Brown Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
EP3597178A1 (de) 2012-06-21 2020-01-22 Phosphorex Inc. Nanopartikel aus indirubin, derivate davon sowie verfahren zur herstellung und verwendung davon
CN103145605A (zh) * 2013-02-27 2013-06-12 广东省微生物研究所 一种1-乙酰基-卤代吲哚基-3-乙酸酯的合成方法
CN103333161B (zh) * 2013-05-28 2015-09-30 滁州市洛达生物科技有限公司 1’-氧代靛玉红的制备和用途
CN104817485B (zh) * 2015-05-18 2017-04-19 安徽师范大学 一种异靛衍生物及其制备方法
CN110683981A (zh) * 2019-09-05 2020-01-14 湖南恒泰生物医药有限公司 一种5-溴-4-氯-1-乙酰基-3-吲哚酚合成方法
CN114920728B (zh) * 2022-05-27 2023-10-20 中南大学 一种甲异靛衍生物及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541244A (ja) * 1999-04-12 2002-12-03 ゲルハルト アイゼンブランド インジゴイドビスインドール誘導体
CA2469649C (en) * 2001-12-13 2011-05-03 Natrogen Therapeutics, Inc. Derivatives of isoindigo, indigo and indirubin and use in treating cancer
US6566341B1 (en) * 2001-12-13 2003-05-20 Natrogen Therapeutics, Inc. Derivative of isoindigo, indigo and indirubin for the treatment of cancer
CN1199946C (zh) * 2002-10-29 2005-05-04 无锡杰西医药科技有限公司 一种特异性吲哚类化合物及制备方法与其在治疗和预防癌症等疾病中的应用
CN100515389C (zh) 2004-07-14 2009-07-22 无锡杰西医药科技有限公司 一种适用于难溶性药物的药用乳剂及其制备方法
CN1329376C (zh) 2005-09-19 2007-08-01 无锡杰西医药科技有限公司 一种n（1）－烃基－3′－肟基靛玉红衍生物（i）的制备方法及其医学应用
CN1840196A (zh) 2006-01-27 2006-10-04 无锡杰西医药科技有限公司 一种适用于难溶性药物的分散剂

Also Published As

Publication number Publication date
CN101715452B (zh) 2012-10-10
EP2168964A4 (de) 2010-08-25
JP5216083B2 (ja) 2013-06-19
IL202600A0 (en) 2010-06-30
KR101191851B1 (ko) 2012-10-16
IL202600A (en) 2013-08-29
CA2692922C (en) 2013-11-19
WO2008151558A1 (en) 2008-12-18
AU2008261491B2 (en) 2012-01-19
CA2692922A1 (en) 2008-12-18
KR20100031613A (ko) 2010-03-23
RU2010101144A (ru) 2011-07-20
CN101715452A (zh) 2010-05-26
US8642765B2 (en) 2014-02-04
CN101074229A (zh) 2007-11-21
JP2010529050A (ja) 2010-08-26
AU2008261491A1 (en) 2008-12-18
EP2168964B1 (de) 2011-10-12
CN101074229B (zh) 2010-09-01
EP2168964A1 (de) 2010-03-31
US20100137356A1 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
ATE528308T1 (de) Gekoppelte azaindol-indol-derivate, herstellungsverfahren und anwendungen davon
EA201200471A1 (ru) Простые эфирные производные бициклических гетероарилов
CY1113269T1 (el) Παραγωγα ινδαζολυλ αμιδιου για τη θεραπευτικη αγωγη διαταραχων διαμεσολαβουμενων υπο υποδοχεα γλυκοκορτικοειδων
CY1111203T1 (el) 4-ανιλινοκινολινο-3-καρβοξαμιδια ως αναστολεις κινασης csf-1r
EA201070841A1 (ru) НОВЫЕ ПИРАЗОЛО[3,4-d]ПИРИМИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ПРОТИВОРАКОВЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ
EA201001769A1 (ru) Производные хинолинов и хиноксалинов в качестве ингибиторов протеинтирозинкиназы
NO20092033L (no) Nye forbindelser
MA37206B1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
NO20092737L (no) Substituerte pyrazolo-kinazolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som kinase-inhibitorer
EA200600322A1 (ru) β-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
UY32025A (es) Derivados sustituídos de la 6-cloro-2-hidroxi-3-(3,4-dioxo-ciclobut-1-enil-amino)-n-metoxi-n-metil-bencen-sulfonamida, solvatos, hidratos o sales farmacéuticamente aceptables de los mismos, proceso de preparación, composiciones y aplicaciones.
MX2010004491A (es) Derivados de piridina y pirazina utiles en el tratamiento de trastornos proliferativos celulares.
TW200732323A (en) Organic compounds
ATE536172T1 (de) Ezetimibzusammensetzungen
UY31016A1 (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
EA201270359A1 (ru) Терапевтическое средство от расстройств настроения
UY32055A (es) Derivados sustituidos de la 5-Halo-N2-[sustituido](1-metil-1H-imidazol-4-il)pirimidin-2,-diamina y sus sales farmacéuticamente aceptables, procesos de preparación, composiciones y aplicaciones.
JO2734B1 (en) Organic compounds
CY1113197T1 (el) Παραγωγα 5-υδροξυμεθυλ- οξαζολιδιν-2-ονης για την αντιμετωπιση βακτηριακων νοσων του εντερου
WO2015002755A3 (en) Compounds for the treatment of malaria
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
CY1114704T1 (el) Κρυσταλλικη μορφη δ του αλατος αργινινης της περινδοπριλης, μεθοδος παρασκευης της και φαρμακευτικες συνθεσεις οι οποιες την περιεχουν
NO20073295L (no) Nye naftalenforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
EA200970570A1 (ru) Макролидные соединения, обладающие противовоспалительной активностью

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties